BTEC.L vs. XSHC.L
BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) and XSHC.L (Xtrackers MSCI USA Health Care UCITS ETF 1D) are both Health & Biotech Equities funds - BTEC.L tracks the NASDAQ Biotechnology NET Index while XSHC.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, BTEC.L returned 5.87%/yr vs 5.47%/yr for XSHC.L. A 0.65 correlation means they provide meaningful diversification when combined. BTEC.L charges 0.35%/yr vs 0.12%/yr for XSHC.L.
Performance
BTEC.L vs. XSHC.L - Performance Comparison
Loading charts...
Different Trading Currencies
BTEC.L is traded in USD, while XSHC.L is traded in GBp. To make them comparable, the XSHC.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BTEC.L achieves a 15.22% return, which is significantly higher than XSHC.L's 2.66% return.
BTEC.L
- 1D
- 0.68%
- 1M
- 9.55%
- 6M
- 13.18%
- YTD
- 15.22%
- 1Y
- 50.31%
- 3Y*
- 16.99%
- 5Y*
- 5.87%
- 10Y*
- —
XSHC.L
- 1D
- 0.84%
- 1M
- 4.76%
- 6M
- 1.94%
- YTD
- 2.66%
- 1Y
- 21.07%
- 3Y*
- 8.11%
- 5Y*
- 5.47%
- 10Y*
- —
BTEC.L vs. XSHC.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 15.22% | 32.96% | -2.04% | 6.22% | -11.92% | -0.49% | 27.40% | 25.57% | -8.74% |
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | 2.66% | 14.90% | 2.35% | 1.51% | -3.42% | 26.97% | 13.34% | 21.40% | 4.83% |
Correlation
The correlation between BTEC.L and XSHC.L is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (All Time) Calculated using the full available price history since Apr 23, 2018 | 0.65 |
The correlation between BTEC.L and XSHC.L has been stable across timeframes, ranging from 0.59 to 0.65 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEC.L vs. XSHC.L — Risk / Return Rank
BTEC.L
XSHC.L
BTEC.L vs. XSHC.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTEC.L | XSHC.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.21 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.24 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 6.22 | 1.92 | +4.30 |
| Martin ratioReturn relative to average drawdown | 19.15 | 4.67 | +14.48 |
Loading charts...
Drawdowns
BTEC.L vs. XSHC.L - Drawdown Comparison
The maximum BTEC.L drawdown since its inception was -38.42%, which is greater than XSHC.L's maximum drawdown of -26.83%. Use the drawdown chart below to compare losses from any high point for BTEC.L and XSHC.L.
Loading charts...
Drawdown Indicators
| BTEC.L | XSHC.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.42% | -26.83% | -11.59% |
Max Drawdown (1Y)Largest decline over 1 year | -7.94% | -10.92% | +2.98% |
Max Drawdown (3Y)Largest decline over 3 years | -26.74% | -17.41% | -9.33% |
Max Drawdown (5Y)Largest decline over 5 years | -38.42% | -17.41% | -21.01% |
Current DrawdownCurrent decline from peak | -3.87% | -3.05% | -0.82% |
Average DrawdownAverage peak-to-trough decline | -13.22% | -4.97% | -8.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 4.50% | -1.92% |
Volatility
BTEC.L vs. XSHC.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) has a higher volatility of 5.91% compared to Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) at 5.52%. This indicates that BTEC.L's price experiences larger fluctuations and is considered to be riskier than XSHC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEC.L | XSHC.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.91% | 5.52% | +0.39% |
Volatility (6M)Calculated over the trailing 6-month period | 15.67% | 11.34% | +4.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.42% | 15.15% | +5.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.39% | 14.86% | +6.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.37% | 16.28% | +6.09% |
BTEC.L vs. XSHC.L - Expense Ratio Comparison
BTEC.L has a 0.35% expense ratio, which is higher than XSHC.L's 0.12% expense ratio.
Dividends
BTEC.L vs. XSHC.L - Dividend Comparison
BTEC.L has not paid dividends to shareholders, while XSHC.L's dividend yield for the trailing twelve months is around 1.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | 1.23% | 1.25% | 1.24% | 1.23% | 1.55% | 0.85% | 1.12% | 0.98% |
Frequently Asked Questions
BTEC.L and XSHC.L have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XSHC.L is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XSHC.L is cheaper with a 0.12% expense ratio, compared with 0.35% for BTEC.L.
BTEC.L tracks NASDAQ Biotechnology NET Index, while XSHC.L tracks MSCI World/Health Care NR USD. They also come from different issuers: iShares and Xtrackers. Their fees differ too: 0.35% for BTEC.L and 0.12% for XSHC.L.
Find the right allocation for BTEC.L and XSHC.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer